NCT03291782View on ClinicalTrials.gov

D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

September 13, 2017

Primary Completion Date

April 6, 2018

Study Completion Date

August 6, 2018

Conditions
Gout
Interventions
DRUG

D-0120

oral, single dose

Trial Locations (1)

32117

Covance Daytona Beach Clinical Research Unit, Daytona Beach

Sponsors
All Listed Sponsors
lead

InventisBio Co., Ltd

INDUSTRY